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Kikuchi-Fujimotodiseaseisaself-limitedbenignconditionofunknownetiologycharacterizedbycervicallymphadenopathy,fever,
and leucopenia. An autoimmune hypothesis has been suggested and an association with systemic lupus erythematosus, Sjogren’s
disease, and antiphospholipid syndrome has been noted. We report a 27-year-old male who presented for evaluation of weakness
and he was diagnosed with seropositive generalized myasthenia gravis and underwent a thymectomy. He was stable until ﬁve
months post-thymectomy, when he developed a high fever associated with nontender cervical lymphadenopathy, chills, and night
sweats. Histopathology of a cervical lymph gland biopsy was compatible with Kikuchi-Fujimoto lymphadenitis. He improved
spontaneously and was asymptomatic at the followup six months later. Our case expands the association of Kikuchi-Fujimoto
disease with autoimmune disorders to include myasthenia gravis.
1.Introduction
Kikuchi-Fujimoto disease (KFD) also known as histiocytic
necrotizing lymphadenitis or necrotizing granulomatous
lymphadenitis is a rare disease of unclear etiology. This
condition was ﬁrst described in Japanese patients by Kikuchi
and Fujimoto independently but simultaneously in 1972
[1,2].Sincethen,ithasbeendescribedindiversepopulations
from North America and Europe [2]. It aﬀects women
more often than men with a ratio of 4:1 and with age
of onset typically 20–30 years. Clinically, it is characterized
by fever, cervical lymphadenopathy, leucopenia, and other
constitutional symptoms [3]. The incidence is estimated to
range between 0.5% and 5% of all cases of pathologically
analyzed lymphadenopathy [4]. Pathologically, the disease is
characterized by coagulative necrosis, histiocytic inﬁltrate,
loss of nodal architecture, and absence of polymorphonu-
clear leukocytes [2]. To diagnose KFD histologically, the
following criteria are used: (a) patchy, irregular areas of
eosinophilic necrosis in the paracortex and/or the cortex
(brick red necrosis), (b) pronounced fragments of nuclear
dust distributed in an irregular fashion through the area of
necrosis, (c) absence of granulocytes and a paucity of plasma
cells, (d) clusters of plasmacytoid T cells, and (e) numerous
immunoblasts predominantly of T-cell phenotype [2, 5].
The cause of KFD is unclear but various antigen-
induced hyperimmune reactions and/or an autoimmune
process where apoptosis occurs have been proposed in the
pathophysiology [4]. Although no direct cause and eﬀect
relationship has been established, several viruses including
Epstein-Barr virus (EBV), parvovirus B19, and human
herpes virus-six have been implicated as these potential
antigens [1]. Dorfman and Berry suggest that KFD may be
anattenuatedformofsystemiclupuserythematosus(SLE)as
the similarities in the lymph node histology are striking [1].
Kikuchi-Fujimoto diseasehasbeen associatedwithanumber
of autoimmune diseases such as SLE, mixed connective
tissue disease, antiphospholipid antibody syndrome, thy-
roiditis, polymyositis, scleroderma, autoimmune hepatitis,
and Still’s disease. In this paper, we expand the association
ofKFDwithanotherautoimmunedisease,myastheniagravis
(MG).2 Case Reports in Medicine
2.CaseReport
A 27-year-old man presented to the Neuromuscular clinic at
the New Jersey Neuroscience Institute/JFK Medical Center
for evaluation of weakness. After a neurological examination
and the further investigations were performed, he was
diagnosed with seropositive generalized MG. He underwent
a thymectomy, and pathological examination showed mild
follicular hyperplasia of thymic tissue. Post-thymectomy, he
was treated with 2.0grams/kg intravenous immunoglobulin
(IVIG) every month in addition to pyridostigmine. He was
neurologically stable, and about approximately ﬁve months
later he developed a persistent high-grade fever (101.4–
104.0F) associated with chills and rigor.
Thefeverwashigherintheevening,associatedwithnight
sweats, and it persisted even after the IVIG was discontinued.
There was no associated skin rash, weight loss, cough,
chest pain, or shortness of breath. His physical examination
was unremarkable except for bilaterally palpable nontender
anterior and posterior cervical, supraclavicular, and axillary
lymphadenopathy. There was no epitrochlear or inguinal
lymph nodal involvement and no hepatosplenomegaly.
Routine investigations showed the following abnormali-
ties: white blood cell count (WBC): 1.71 (4.5–11×109/liter),
serum lactate dehydrogenase (LDH): 832 (100–225U/l),
alanine transaminase and aspartate aminotransferase were
85 (8–30)U/L and 132 (0–55)U/L, respectively; erythrocyte
sedimentation rate (ESR) was 132 (0–15mm/hr); the C-
reactive protein (CRP) was 20.95 (0–5mg/L).
The following investigations were either normal or
negative: blood cultures for bacteria, viruses and fungi,
serology against EBV, cytomegalovirus, parvovirus B19,
histoplasmosis, borrelia burgdorferi, human immunodeﬁ-
ciency virus, hepatitis B virus, hepatitis C virus, treponema
pallidum, antinuclear antibody test, anti-double-stranded
DNA antibody, anti-sm antibody, and anti-Sj¨ ogren’s syn-
drome A (anti-SSA) and anti-Sj¨ ogren’s syndrome B (anti-
SSB) antibodies.
A spiral computed tomography (CT) scan of the neck
with contrast conﬁrmed many clusters of almost all groups
of cervical lymphadenopathy, the largest measuring 2.29 ×
1.24×2.71cm.Therewasnomediastinalorhilaradenopathy
on chest CT. A ﬁne needle aspiration biopsy of a cervical
lymph gland was performed, and cultures for bacterial
(including acid-fast bacillus) and fungal organisms were
negative.However,histologicalexaminationshowedanecro-
tizing histiocytic lymphadenitis consistent with Kikuchi-
Fujimoto lymphadenitis (Figure 1).
Symptomatic treatment of the fever was instituted and
lymphadenopathy resolved spontaneously. Six months after
lymph node biopsy, the cervical and axillary lymphadenopa-
thy had resolved. In addition, routine serum chemistries
including his WBC count and liver functions tests had all
returned to normal.
3. Discussion
Kikuchi-Fujimoto disease is an enigmatic, benign, and self-
limited disease presenting with an acute or subacute onset
(a)
(b)
(c)
Figure 1: Hematoxylin- and eosin-stained section showing histo-
logical appearance of a lymph node biopsy in medium (a) and
high (b, c) magniﬁcations. (a) Lymph node showing necrosis and
mononuclear cell inﬁltrate (arrow). (b) Brick red necrosis (arrow).
(c) Apoptosis and nuclear dust (arrow). (a, b, and c) x10 (original
magniﬁcation).
and progression over two to three weeks. Lymphadenopathy
is the most frequent sign with cervical lymphadenopathy
observed 74%–90% of time, especially in the posterior
cervical triangle. The nodes are ﬁrm in consistency and
may be tender. In 30%–50% of patients, fever is the
presenting symptom [4, 6]. Other symptoms and signs
include splenomegaly, weight loss, arthralgia, and skin rash.
The latter is seen in one third of patients at presentation
leading to confusion in the clinical scenario with infectious
mononucleosis, SLE, and lymphoma. There is leucopenia
in 25%–50% of cases with nonspeciﬁc ﬁndings of elevated
LDH, transaminases, ESR, and CRP [1, 7].
Our patient has both the clinical and histological criteria
conﬁrmingthediagnosisofKFD.Thereisareportofpossible
treatment of KFD with IVIG [8]. However, our patient
developed KFD while on IVIG, raising doubts about its
therapeutic utility in this condition.Case Reports in Medicine 3
This is the ﬁrst report of a patient with both KFD
and MG and expands the growing list of autoimmune
diseases that can be associated with KFD. Although KFD
undergoes a spontaneous resolution in 3–6 months, long-
term monitoring is recommended as recurrence is known to
occur in 3% of cases [4].
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